Sanofi India Limited
₹3,079.20
-0.86%
Delayed · cached 15 min
Fair value analysis
SANOFI
Sanofi India Limited
₹3,106.00
Close used for this calculation
₹3,830.64Fair value
Financial DNA Score
Profitability · Returns · Balance Sheet · Efficiency · Growth
64/100
Quality radar
Consensus fair value
₹3,830.64
Below FV▲ +23.3% against the close used
Model range ₹966.28 – ₹6,415.29
The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹966.28Fair value₹3,830.64Bull₹6,415.29
FairClose
52-week traded range
52W low ₹3,097.1052W high ₹5,077.00
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Sanofi India Limited closed at ₹3,106.00, 18.9% below the consensus fair value of ₹3,830.64 drawn from 8 valuation models.
Financial DNA score 64/100 — Good. P/E of 16.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹3,497.29
+12.6%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹1,277.92
-58.9%
√(22.5 × EPS × BVPS)
EPS=179.7, BVPS=403.9 · outside Graham range (P/E 16, P/B 7.7) — asset-light, treat as a rough floor
P/E Fair Value
₹6,415.29
+106.5%
EPS × 35.7x (sector P/E)
EPS=179.7, Sector P/E=35.7x
EV/EBITDA
₹2,304.42
-25.8%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=5.28B
Dividend Discount (DDM)
₹966.28
-68.9%
D1 ÷ (r − g) where D1 = D0×(1+g)
D0=75.79, r=10%, g=2%
Book Value (P/B)
₹2,544.58
-18.1%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=403.9, ROE=47.1%, g=3%, r=10%
Reverse DCF
₹3,106.00
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 5.2% | Historical: 0%
Margin of Safety
₹2,797.63
-9.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=3730.17, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.